is selling its Archimedes subsidiary, a healthcare modeling firm, to Evidera and its parent private equity backer, Symphony Technology Group. Terms of the deal were not disclosed.
"We are committed to continuing the mission of the original intent of Archimedes and its model of quantitative healthcare," Dr. Jed Weissberg, senior vice president, hospitals, quality and care delivery excellence at Kaiser Permanente, said in a news release announcing the deal. "The buyer, Symphony/Evidera, is a great home to enable the scientists to further their pursuits to enable personalized care for the future of medicine."
San Francisco-based Archimedes applies its modeling techniques for clients in the areas of health economics, public health
and healthcare policy
. Its IndiGo division combines real-world data and simulations in reviewing healthcare decisionmaking regarding treatments and preventive care. Those will be new areas for Evidera, whose offerings include health economics, outcomes research, market access, data analytics
and epidemiology services. Evidera plans to expand the disease areas Archimedes models for.
“I have long admired their vision and their dedication to producing the most valid healthcare model possible. I look forward to working with the Archimedes staff to take it to the next level,” said Jaime Caro, Evidera's senior vice president of research.
Evidera is headquartered in Bethesda, Md., but also has an office in Seattle, so Archimedes will be its second West Coast outpost. Follow John N. Frank on Twitter:@MHJFrank